TNFRSF10B and ovarian carcinoma: Our results showed that high expression of DR5 (TNFRSF10B) was significantly associated with improved overall survival in patients with ovarian cancer (n = 278, HR: 0.65, Cox p-value: 0.027138) (Fig. 4e).